BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 27035928)

  • 21. Can a gene-expression classifier with high negative predictive value solve the indeterminate thyroid fine-needle aspiration dilemma?
    Faquin WC
    Cancer Cytopathol; 2013 Mar; 121(3):116-9. PubMed ID: 23364882
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Galectin-3-expression analysis in the surgical selection of follicular thyroid nodules with indeterminate fine-needle aspiration cytology: a prospective multicentre study.
    Bartolazzi A; Orlandi F; Saggiorato E; Volante M; Arecco F; Rossetto R; Palestini N; Ghigo E; Papotti M; Bussolati G; Martegani MP; Pantellini F; Carpi A; Giovagnoli MR; Monti S; Toscano V; Sciacchitano S; Pennelli GM; Mian C; Pelizzo MR; Rugge M; Troncone G; Palombini L; Chiappetta G; Botti G; Vecchione A; Bellocco R;
    Lancet Oncol; 2008 Jun; 9(6):543-9. PubMed ID: 18495537
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The diagnostic accuracy of ultrasound-guided fine-needle aspiration biopsy and the sonographic differences between benign and malignant thyroid nodules 3 cm or larger.
    Yoon JH; Kwak JY; Moon HJ; Kim MJ; Kim EK
    Thyroid; 2011 Sep; 21(9):993-1000. PubMed ID: 21834673
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Genetic markers differentiating follicular thyroid carcinoma from benign lesions.
    Freitas BC; Cerutti JM
    Mol Cell Endocrinol; 2010 May; 321(1):77-85. PubMed ID: 19932149
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Diagnostic and extent of disease multigene assay for malignant thyroid neoplasms.
    Kebebew E; Peng M; Reiff E; McMillan A
    Cancer; 2006 Jun; 106(12):2592-7. PubMed ID: 16688775
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Immunohistochemical Subcellular Localization of Protein Biomarkers Distinguishes Benign from Malignant Thyroid Nodules: Potential for Fine-Needle Aspiration Biopsy Clinical Application.
    Ralhan R; Veyhl J; Chaker S; Assi J; Alyass A; Jeganathan A; Somasundaram RT; MacMillan C; Freeman J; Vescan AD; Witterick IJ; Walfish PG
    Thyroid; 2015 Nov; 25(11):1224-34. PubMed ID: 26131603
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Multicenter clinical experience with the Afirma gene expression classifier.
    Alexander EK; Schorr M; Klopper J; Kim C; Sipos J; Nabhan F; Parker C; Steward DL; Mandel SJ; Haugen BR
    J Clin Endocrinol Metab; 2014 Jan; 99(1):119-25. PubMed ID: 24152684
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The Bethesda thyroid fine-needle aspiration classification system: year 1 at an academic institution.
    Theoharis CG; Schofield KM; Hammers L; Udelsman R; Chhieng DC
    Thyroid; 2009 Nov; 19(11):1215-23. PubMed ID: 19888859
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Ultrasonographic features associated with malignancy in cytologically indeterminate thyroid nodules.
    Batawil N; Alkordy T
    Eur J Surg Oncol; 2014 Feb; 40(2):182-6. PubMed ID: 24373298
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A panel of four miRNAs accurately differentiates malignant from benign indeterminate thyroid lesions on fine needle aspiration.
    Keutgen XM; Filicori F; Crowley MJ; Wang Y; Scognamiglio T; Hoda R; Buitrago D; Cooper D; Zeiger MA; Zarnegar R; Elemento O; Fahey TJ
    Clin Cancer Res; 2012 Apr; 18(7):2032-8. PubMed ID: 22351693
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evaluation of genetic biomarkers for distinguishing benign from malignant thyroid neoplasms.
    Nagar S; Ahmed S; Peeples C; Urban N; Boura J; Thibodeau B; Akervall J; Wilson G; Long G; Czako P
    Am J Surg; 2014 Apr; 207(4):596-601. PubMed ID: 24713092
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of malignancy rate in thyroid nodules with cytology of indeterminate follicular or indeterminate Hürthle cell neoplasm.
    Sorrenti S; Trimboli P; Catania A; Ulisse S; De Antoni E; D'Armiento M
    Thyroid; 2009 Apr; 19(4):355-60. PubMed ID: 19355826
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Detection of RET/PTC, TRK and BRAF mutations in preoperative diagnosis of thyroid nodules with indeterminate cytological findings.
    Sapio MR; Posca D; Raggioli A; Guerra A; Marotta V; Deandrea M; Motta M; Limone PP; Troncone G; Caleo A; Rossi G; Fenzi G; Vitale M
    Clin Endocrinol (Oxf); 2007 May; 66(5):678-83. PubMed ID: 17381488
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Differentiating benign from malignant thyroid nodules using micro ribonucleic acid amplification in residual cells obtained by fine needle aspiration biopsy.
    Mazeh H; Levy Y; Mizrahi I; Appelbaum L; Ilyayev N; Halle D; Freund HR; Nissan A
    J Surg Res; 2013 Apr; 180(2):216-21. PubMed ID: 22626557
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Methylation status of TSHr in well-differentiated thyroid cancer by using cytologic material.
    Kartal K; Onder S; Kosemehmetoglu K; Kilickap S; Tezel YG; Kaynaroglu V
    BMC Cancer; 2015 Oct; 15():824. PubMed ID: 26519197
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prevalence and prediction of malignancy in cytologically indeterminate thyroid nodules.
    Sahin M; Gursoy A; Tutuncu NB; Guvener DN
    Clin Endocrinol (Oxf); 2006 Oct; 65(4):514-8. PubMed ID: 16984245
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Approach to the patient with a cytologically indeterminate thyroid nodule.
    Alexander EK
    J Clin Endocrinol Metab; 2008 Nov; 93(11):4175-82. PubMed ID: 18987277
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Assessment of molecular testing in fine-needle aspiration biopsy samples: an experience in a Chinese population.
    Liu S; Gao A; Zhang B; Zhang Z; Zhao Y; Chen P; Ji M; Hou P; Shi B
    Exp Mol Pathol; 2014 Oct; 97(2):292-7. PubMed ID: 25111330
    [TBL] [Abstract][Full Text] [Related]  

  • 39. 'Indeterminate for malignancy' (Tir3/Thy3 in the Italian and British systems for classification) thyroid fine needle aspiration (FNA) cytology reporting: morphological criteria and clinical impact.
    Pagni F; Prada M; Goffredo P; Isimbaldi G; Crippa S; Di Bella C; Leone BE;
    Cytopathology; 2014 Jun; 25(3):170-6. PubMed ID: 23937572
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Quantitative diffusion-weighted magnetic resonance imaging as a powerful adjunct to fine needle aspiration cytology for assessment of thyroid nodules.
    Nakahira M; Saito N; Murata S; Sugasawa M; Shimamura Y; Morita K; Takajyo F; Omura G; Matsumura S
    Am J Otolaryngol; 2012; 33(4):408-16. PubMed ID: 22154066
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.